Trends in Anticancer Drug Pricing: Analyzing Me...

By João L. Carapinha

May 20, 2025

The recent JAMA article examines anticancer drug pricing for self-administered medications covered under Medicare Part D from 2010 to 2024. It focuses on the effects of the Inflation Reduction Act (IRA) of 2022. This study reveals a consistent upw...
EMA AI Tool Qualification: How the AIM-NASH Approval Sets a Roadmap for Medic...
Publication Delays Impact Careers of Early-Career Researchers
A System Dynamics Approach to Lowering Drug Prices by 30–80% in the US
EFPIA Advocates for Stronger Life Sciences in EU Multiannual Financial Framework
Evolving NICE Health Technology Evaluations: Enhancing Patient Perspectives a...
Canada Drug Agency Plan: Shaping the Future of Health Systems 2025-2030
VIETNARMS Trial Unveils Innovative Hepatitis C Treatment Options
Revolutionizing Hepatitis C Treatment: The Transformative Role of Direct-Acti...
Hepatitis C Investment Impact: Maximizing Health and Economic Returns in China
First At-Home HPV Testing Approval: FDA Clears Teal Wand
MR-107A-02: Revolutionizing Non-Opioid Pain Management with Viatris’ Breakthr...
Bulevirtide HDV Therapy: Promising Results in Durable Virologic Control